The Comparative Effect of Definitive Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Plus Surgery on One-Year Survival Rate of Esophageal Cancer Patients

Background: Esophageal cancer is a malignancy with poor survival rate, and the optimal management of esophageal patients still controversial. This study aimed to compare one-year who had received definitive chemoradiotherapy (DCRT) or neoadjuvant plus surgery (NCRT+S). Materials Methods: In this cross-sectional descriptive study, medical records were extracted from 2018 2019; last status was obtained one year after end treatment course. Data analyzed using SPSS (version 16), estimated by Kaplan-Meier method log-rank test. A P value less than 0.05 considered significant for all performed tests. Results: Among 43 eligible patients, 39.5% males 60.5% females. The mean age 68.16±12.03 years. population, 81.4% cases squamous cell carcinoma (SCC), rest adenocarcinoma (ADC). addition, 58.1% 41.9% treated DCRT NCRT+S, respectively. rate 68% 66.67% in NCRT+S groups, respectively (P>0.05). did not have relevance histologic subtype. terms gender, there no difference between females regarding rate. Conclusion: There statistically differences two groups; thus, further studies are recommended confirm results.